Company Profile

OraPharma Inc.

Profile date: 2025-01-01

OraPharma Inc. - Specialty Pharmaceutical Focus on Oral Health

OraPharma Inc. is a specialty pharmaceutical corporation based in the United States, operating as an oral health care business line under Bausch Health Companies Inc. The company's core mission centers on developing and commercializing scientifically and technologically advanced products specifically designed to improve and maintain oral health. Its strategic focus is primarily on supplying dental professionals???including general dentists, hygienists, periodontists, and oral surgeons???with innovative, science-based solutions for their practices and patients. OraPharma's offerings address several key areas within oral healthcare, most notably the treatment of periodontal disease, providing local anesthesia delivery systems, offering regenerative solutions for oral surgery, and managing conditions like dry mouth.

The company is dedicated to advancing the standard of care in dentistry by providing targeted, high-value pharmaceutical and regenerative products. As a specialty pharma entity, its activities include ongoing patient and clinician education, particularly concerning the prevalence, impact, and treatment of conditions such as adult periodontitis.

Products and Services

OraPharma???s portfolio is concentrated on therapeutic and regenerative solutions used by dental professionals, with several key products forming the foundation of its business:

ARESTIN (minocycline HCl) Microspheres, 1 mg
- Function: This is the company's flagship product and a locally administered antibiotic (LAA).
- Application: It is indicated for use in combination with Scaling and Root Planing (SRP) procedures to treat patients suffering from adult periodontitis (gum disease).
- Technology: ARESTIN utilizes patented microsphere technology, which allows the antibiotic to be placed directly into the periodontal pocket, providing a sustained release of minocycline at the site of infection for an extended period, thereby fighting the bacteria that cause gum disease as an adjunct to the mechanical cleaning provided by SRP. OraPharma is recognized as a pioneer in the field of locally administered antibiotics for periodontitis.
ONSET
- Function: A unique delivery system for local anesthesia.
- Application: ONSET is designed to provide locally buffered anesthesia. Buffering the anesthetic solution immediately prior to injection normalizes its pH, which can lead to a more comfortable injection experience and a faster onset of anesthesia for the patient, a significant benefit in common dental procedures.
OSSIX PLUS
- Function: A resorbable dental barrier membrane designed for Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) procedures.
- Application: This product is critical in oral surgery and periodontics. It is used to aid in the regeneration of bone and tissue, supporting procedures such as ridge augmentation, sinus lifts, and dental implant placement where a barrier is needed to prevent soft tissue from growing into the space intended for bone regeneration. OSSIX PLUS is made from a naturally derived collagen material.
NEUTRASAL
- Function: A prescription rinse for the oral cavity.
- Application: This product is formulated to treat and manage the symptoms of dryness of the oral mucosa, commonly known as xerostomia or dry mouth, which can result from various medical conditions, medications, or radiation therapy. The rinse helps to moisturize and soothe the oral tissues.
EZ White
- Function: A professional dental product for tooth whitening.
- Application: This is a cosmetic solution offered through dental professionals for patients seeking to lighten the color of their teeth under clinical supervision.

In summary, OraPharma Inc. functions as a dedicated partner to the dental community, focusing its resources on the pharmaceutical and MedTech segments of oral health. Its product pipeline is aimed at therapeutic and regenerative solutions, positioning the company as a key contributor to the management of chronic oral diseases and complex surgical needs. The emphasis on products like ARESTIN highlights the company's commitment to delivering advanced, evidence-based treatments for pervasive conditions like periodontitis, which affects a large percentage of the adult population.

Please note: This information is generated by AI. For legal use, verify with company sources.